Rate this content: 
Average: 4.7 (3 votes)
UK | January 2022 | 164592
Top banner. GP letter
Rate this content: 
Average: 5 (1 vote)
UK | June 2021 | 103440

Prescribing information

The patient support programme which offers patients and healthcare professionals access to nurses and specially developed materials to help patients through the first year of their GILENYA®▼ (fingolimod) journey.Show more

Rate this content: 
Average: 3.5 (2 votes)
GIL19-C053d(1) November 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com